Botanical API

a cGMP botanical API manufacturer and contract manufacturing organization (CMO) specializing in food and pharmaceutical-grade botanical raw material sourcing, botanical extract production, standardized botanical drug substance manufacturing, and Drug Master File (DMF) preparation. We supply botanical APIs to food and pharmaceutical industries,

What Is a Botanical API?

A botanical API (Active Pharmaceutical Ingredient) is a food or pharmaceutical-grade substance derived from plant material — including botanical extracts, standardized herbal concentrates, and purified phytochemical fractions — that serves as the active ingredient in food or botanical drug products. Unlike synthetic APIs derived from a single isolated chemical compound, a botanical API is inherently complex, often containing hundreds of bioactive constituents that collectively contribute to its effect.

This chemical complexity is what makes botanical API manufacturing fundamentally different from conventional pharmaceutical manufacturing — and why cGMP-compliant botanical API production requires specialized analytical and manufacturing expertise.

Botanical Extract vs. Botanical API: What Is the Difference?

Not all botanical extracts qualify as pharmaceutical-grade botanical APIs. Understanding the distinction is critical for sponsors planning an FDA botanical drug development program:

Crude Botanical Extract — A basic concentration of plant material with minimal standardization. Suitable for food or supplement use, but insufficient for FDA botanical drug submissions without additional pharmaceutical-grade processing and characterization.
Standardized Botanical Extract — A botanical extract normalized to a defined concentration of one or more marker compounds. A step toward pharmaceutical quality, but typically requires further cGMP manufacturing and analytical characterization to qualify as a botanical API for IND or NDA submissions.
Pharmaceutical-Grade Botanical API — A fully cGMP-manufactured, analytically characterized botanical drug substance meeting FDA IND and NDA CMC requirements — including chemical fingerprinting, impurity profiling, stability testing, and Drug Master File (DMF) documentation.

We specialize exclusively in botanical API manufacturing — supplying botanical drug substance to sponsors developing FDA-approved botanical drugs or botanical extracts to food industry.

Contract Manufacturing (CMO) Services

We provide end-to-end botanical API contract manufacturing services — from GACP-certified botanical raw material sourcing through cGMP botanical drug substance production, analytical release testing, and Drug Master File (DMF) preparation. Our botanical CMO services are purpose-built for pharmaceutical sponsors navigating the FDA botanical drug development pathway, supporting programs from early-stage IND preparation through commercial-scale botanical API supply.

Botanical Raw Material Sourcing

Consistent, authenticated botanical raw material is the foundation of every successful botanical API program. Our botanical raw material sourcing network operates exclusively with contracted, GACP (Good Agricultural and Collection Practices)-certified farms, ensuring full field-to-facility traceability for every botanical API batch.

Every incoming botanical raw material lot undergoes rigorous quality evaluation before entering our cGMP manufacturing process:

Pharmacopoeial botanical identity authentication
Heavy metal and elemental impurity screening
Pesticide and agrochemical residue testing
Microbial contamination and mycotoxin safety assessment
Moisture content and physical characteristic evaluation

2. Botanical Extract Production

Our botanical extract production capabilities cover the full spectrum of extraction and concentration technologies required for pharmaceutical-grade botanical API manufacturing. Every botanical extract production process is designed to preserve the complete chemical profile of the botanical raw material — maintaining the multifactorial therapeutic activity that defines botanical drug efficacy.

Water-Based Extraction — Traditional decoction-based extraction aligned with pharmacopoeial botanical drug substance preparation methods
Low-Temperature Filtration — Controlled 40–60°C filtration minimizing thermal degradation of heat-sensitive botanical constituents
Cryoconcentration — ISO Class 6 clean-area concentration preserving botanical extract chemical integrity
Spray Drying — Optimized spray drying converting botanical extracts into stable, standardized botanical API powders
Essential Oil Recovery — Proprietary volatile component capture and Beta-Cyclodextrin encapsulation restoring the full botanical chemical fingerprint
Granulation — Precision particle sizing ensuring botanical drug substance flowability, solubility, and dosing accuracy

3. cGMP Botanical API Manufacturing

Our botanical API manufacturing is conducted under current Good Manufacturing Practice (cGMP) standards in our FDA-registered facility. Our cGMP botanical API manufacturing capabilities support the full clinical development lifecycle — from Phase 1 clinical trial material (CTM) production through commercial-scale botanical drug substance supply.

Every botanical API batch undergoes comprehensive analytical release testing before a Certificate of Analysis (CoA) is issued:

HPLC Quantification — Active botanical marker compound identification and potency confirmation
HPTLC Botanical Fingerprinting — Chemical fingerprint verification ensuring batch-to-batch consistency of the botanical API
LC-MS Profiling — High-resolution mass spectrometry characterization of botanical drug substance constituents
Impurity Profiling — Pesticide residues, heavy metals, and microbial contaminants tested to FDA limits
Stability Testing — ICH Q1A-compliant stability studies establishing botanical API shelf-life specifications
Certificate of Analysis (CoA) — Comprehensive quality documentation issued for every released botanical API batch

4. Drug Master File (DMF) Preparation & Support

A Drug Master File (DMF) is a critical regulatory document that enables pharmaceutical sponsors to reference confidential botanical API manufacturing and quality data in their FDA IND and NDA submissions — without disclosing proprietary manufacturing information to third parties.

We prepares complete Type II DMF packages for botanical drug substances, providing sponsors with the full CMC documentation foundation needed for a successful FDA botanical drug submission:

Complete Type II Botanical API Drug Master File preparation
CMC manufacturing process descriptions and process validation data
Analytical method development and validation documentation
Botanical API stability data meeting ICH Q1A through Q1E requirements
Impurity qualification and botanical characterization data packages
DMF Letters of Authorization (LoA) issued to qualified pharmaceutical sponsors upon request

For sponsors working with American Botanical Drug Corporation (ABDC) on their FDA botanical IND or NDA submission, our botanical API DMF documentation integrates seamlessly with ABDC's regulatory consulting services — providing a fully coordinated botanical drug development solution from raw material sourcing through FDA approval.

Why Choose Us as Your Botanical API Supplier?

Pharmaceutical sponsors developing FDA botanical drugs require a botanical API supplier that understands not just manufacturing — but the full regulatory context of botanical drug development. We combine cGMP botanical API manufacturing expertise with deep knowledge of FDA botanical drug CMC requirements, making us uniquely qualified to support your botanical drug program from raw material sourcing through NDA submission.

cGMP & FDA-Registered Botanical API Manufacturing

We manufacture pharmaceutical-grade botanical APIs under current Good Manufacturing Practice (cGMP) standards in our FDA-registered facility. Every botanical API batch we produce meets the same manufacturing quality standards required for synthetic pharmaceutical APIs — not supplement-grade, not food-grade. For pharmaceutical sponsors submitting botanical INDs and NDAs to the FDA, this distinction is critical.

GACP-Certified Botanical Raw Material Sourcing

Botanical API quality begins at the source. We source all botanical raw materials exclusively from contracted, GACP (Good Agricultural and Collection Practices)-certified farms, ensuring authenticated botanical identity, full field-to-facility traceability, and consistent chemical composition from harvest through finished botanical drug substance. Our GACP-certified sourcing program fully satisfies the raw material documentation requirements of the FDA's 2016 Botanical Drug Development Guidance for Industry.

Botanical Fingerprinting & Batch-to-Batch Consistency

Batch-to-batch chemical consistency is the most critical quality requirement for pharmaceutical-grade botanical APIs — and the area most frequently scrutinized by the FDA in botanical IND and NDA reviews. We apply a multi-layered analytical strategy to verify botanical API consistency across every production batch:

HPLC-based active marker quantification confirming botanical API potency
HPTLC botanical fingerprinting verifying the complete chemical profile of every batch
LC-MS profiling detecting and characterizing low-abundance botanical constituents
Comprehensive impurity testing for pesticides, heavy metals, and microbial contaminants

DMF-Ready Botanical API Documentation

We provide complete Type II Drug Master File (DMF) packages for every botanical API we manufacture — giving pharmaceutical sponsors the full CMC documentation foundation needed for FDA IND and NDA submissions. Our DMF-ready botanical API supply eliminates one of the most common bottlenecks in botanical drug development: the absence of a qualified, fully documented botanical drug substance supplier. Letters of Authorization (LoA) are issued to qualified sponsors upon request.

Full-Spectrum Botanical Extract Technology

Conventional botanical extraction processes frequently lose volatile essential oil components that contribute to the botanical drug's multifactorial therapeutic activity. Our proprietary full-spectrum botanical extraction technology captures and reintegrates volatile botanical constituents — including essential oil recovery, Beta-Cyclodextrin encapsulation, and systematic matrix reintroduction — ensuring the finished botanical API retains the complete chemical fingerprint of the original botanical raw material.

Regulatory Bridge to FDA Botanical Drug Approval

We are affiliated with American Botanical Drug Corporation (ABDC) — an FDA regulatory consulting firm specializing in botanical drug development at botanicaldrug.com. This affiliation gives pharmaceutical sponsors a uniquely integrated botanical drug development solution: pharmaceutical-grade botanical API supply seamlessly coordinated with expert FDA regulatory consulting, IND preparation, CMC strategy, and NDA submission support. From botanical raw material sourcing through FDA approval, our combined capabilities cover the full botanical drug development lifecycle.

Google Sites

Report abuse